DT2219ARL Immunotoxin in Treating Patients With B-Cell Leukemia or Lymphoma That Has Relapsed or Not Responded to Treatment

This study is currently recruiting participants.

Study NCT00889408 Information provided by National Cancer Institute (NCI)

First Received: April 26, 2009 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	April 2012 (Final data collection date for primary outcome measure)